OR WAIT null SECS
Contract service providers must step up their game to stay competitive in increasingly complex bio/pharma market.
The need for preclinical testing expertise is growing as molecular complexity increases.
A look at the newest innovations offers a deeper understanding of affinity ligands and their role in the future of downstream processing.
February 01, 2012
The author examines the opportunities and positioning of contract service providers.
January 02, 2012
Pressure to approve new user fees opens the door to action on drug shortages, prices, and regulation.
As part of the BRIC bloc with Russia, India, and China, Brazil is one of the world's leading emerging economies and is also considered by IMS Health to be one of seven pharmerging nations, which also include Mexico, Turkey, and South Korea.
Some recent private-equity buyouts of CROs show both the upside and downside for investors.
The European Union market takes steps toward continuous processing and modular facilities.
A Q&A with Gilles Cottier, president of SAFC, on recent industry trends.
December 02, 2011
Expansion activity was limited as fine-chemical producers and CMOs of API and intermediates grapple with changing industry fundamentals.
A dearth of late-stage candidates could hurt the pharmaceutical services market in the future.
Cleanliness is crucial, even if zapping and trapping is necessary to reduce product contamination.
Added responsibilities and outside concerns prompt overhaul of agency's structure.